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Abstract
The structural information in high-dimensional transposable data allows us to write the data
recorded for each subject in a matrix such that both the rows and the columns correspond to
variables of interest. One important problem is to test the null hypothesis that the mean matrix
has a particular structure without ignoring the dependence structure among and/or between the
row and column variables. To address this, we develop a generic and computationally inexpensive
nonparametric testing procedure to assess the hypothesis that, in each predefined subset of columns
(rows), the column (row) mean vector remains constant. In simulation studies, the proposed testing
procedure seems to have good performance and, unlike simple practical approaches, it preserves the
nominal size and remains powerful even if the row and/or column variables are not independent.
Finally, we illustrate the use of the proposed methodology via two empirical examples from gene
expression microarrays.
Keywords— High-dimensional transposable data; Hypothesis testing; Mean matrix; Nonpara-
metric test.
1 Introduction
In some applications, the measurements related to each subject are naturally organized in a matrix,
especially when the rows and columns correspond to two different sets of variables and dependencies
are expected to occur between and/or among them. Allen and Tibshirani (2010) introduced the term
‘transposable data’ to acknowledge the structural information and the presence of two-way dependen-
cies in matrix-valued random variables. Examples of transposable data can be found in spatiotemporal
studies (Genton, 2007; Mardia and Goodall, 1993), in cross-classified multivariate data (Galecki, 1994;
Naik and Rao, 2001), in genetics (Allen and Tibshirani, 2010, 2012; Efron, 2009; Teng and Huang,
2009; Yin and Li, 2012; Ning and Liu, 2013), in functional MRI (Allen and Tibshirani, 2010), in time-
series (Carvalho and West, 2007; Lee et al., 2013) and in electroencephalography studies (Zhang et al.,
1995) among others.
Although our findings can be applied to any of the disciplines mentioned above, our work is primar-
ily motivated by biological studies that use microarrays to study gene expression patterns in multiple
tissue samples taken from the same subject (Sottoriva et al., 2013; Zahn et al., 2007). For each subject,
the row variables correspond to genes, the column variables to tissue samples and the measurements
are mRNA gene expression levels. A complex and high-dimensional dependence structure is expected
to occur as neither the genes nor the tissue samples are likely to be independent. In such studies, a
natural biological objective is to determine whether given subsets of tissue samples share a common
mean vector of gene expression levels. This leads to two important statistical challenges. First, the
number of genes will typically exceed the number of subjects and it is a well known fact that classical
1
multivariate tests for testing equality of mean vectors, such as the Hotelling’s T 2 or Wilk’s Λ, are not
applicable in ‘large p, small N ’ settings. Second, the dependence among the tissue samples for each
subject might restrict us from utilizing practical approaches that rely on mixing univariate standard
testing procedures and multiple testing correction methods. This includes, for example, the approach
of testing the significance of each gene across tissue samples based on an analysis of variance (ANOVA)
test and adjusting the corresponding p-values for multiple testing. This approach requires tissue-wise
(column-wise) independence, a rather strong assumption that is unlikely to be met in real datasets.
To introduce these concepts in mathematical terms, suppose that an experimentalist collects N
independent and identically distributed (i.i.d.) transposable r × c random matrices X1, . . . ,XN . For
each subject, there are r row variables and c column variables and the high-dimensional setting is
indicated by letting the sample size (N) be much smaller than the number of observations (rc) for a
single subject. The goal is to perform hypothesis testing forM = E[Xi], the r× c mean matrix of the
transposable data, while accounting for the two-way dependencies.
To illustrate some difficulties of this task, consider the simple hypothesis
H0 :M = µ1
T
c vs. H1 :M 6= µ1Tc , (1)
where µ is an unknown r-variate parameter vector and 1s denotes an s-variate vector of ones. The null
hypothesis suggests that the mean relationship between the row and column variables is completely
determined by the row variables. In the motivating examples, H0 in (1) is consistent with no genes
showing differential expression across the multiple tissue samples. To the best of our knowledge,
no statistical procedure exists to test hypothesis (1) directly in high-dimensional transposable data
unless there are only two dependent column variables (c = 2). In this case, the test proposed by
Chen and Qin (2010) for comparing the mean vector of paired high-dimensional random vectors can
be used. To accomplish this, one needs to form the vector of the difference of the two columns for each
subject and then test the hypothesis of a zero mean vector. Unfortunately, there is no straightforward
way to apply or extend this test when c > 2. In particular, attempts to do this essentially infer rather
than test the mean relationship between the row and column variables. For example, suppose that
M = [µ,−µ,µ,−µ] and consider the following naive algorithm to test hypothesis (1). First, create
two groups of column variables, one based on the first two columns and the other based on the last
two. Second, for each group create N r-variate random vectors by averaging the appropriate columns
in each matrix, and then for each subject create the r-variate vectors of the difference of the two
groups. Thirdly, test hypothesis (1) using the test statistic of Chen and Qin (2010) as above. It can
be shown that this vector-based test statistic will be powerless since the transformed random vectors
will indeed have a zero mean vector.
By contrast, we propose a simple approach to test hypothesis (1) that overcomes these theoretical
problems. In this direction, let Pc = Ic − Jc/c where Is is the identity matrix of size s and Js is the
s × s matrix of ones, and let tr(A) denote the trace operator of the matrix A. Note that Pc is a
symmetric and idempotent (P2c = Pc) matrix such that tr(M
T
MPc) = 0 if and only if H0 in (1) holds.
Since the Frobenius norm, tr(MTMPc), measures deviations from H0 in (1), it seems meaningful to
develop a test statistic based on
∑
i 6=j tr(X
T
i XjPc)/[N(N − 1)], the unbiased estimator of this norm.
Under rather weak conditions about the two-way dependence structure, illustrated in Section 2.3,
this estimator asymptotically follows a normal distribution, and hence, the critical region of the test
statistic can be defined under H0.
The main contribution of this paper is that we allow testing more complicated hypotheses than
hypothesis (1) for the mean matrix. In particular, we consider the hypothesis
H0 :M = [µ11
T
c1 ,µ21
T
c2 , . . . ,µg1
T
cg ] vs. H1 :M 6= [µ11Tc1 ,µ21Tc2 , . . . ,µg1Tcg ], (2)
where c1, . . . , cg are positive integers such that
∑g
q=1 cq = c with at least one cq ≥ 2 and µ1, . . . ,µg
are g unknown r-variate parameter vectors. H0 in (2) states that in each one of the given g column
groups there is no column effect upon the mean of the row variables. Since g is known but arbitrary,
the proposed testing procedure is not bounded by the number of column groups or the group size
under consideration. For example, hypothesis (1) is a special case of hypothesis (2) with g = 1 and
c1 = c while the hypothesis that two column variables, say the first two, have a common mean vector
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is obtained by setting g = c − 1, c1 = 2 and c2, . . . , cg = 1. Similarly to testing hypothesis (1),
the proposed test statistic will be based on an asymptotic argument via a pivotal quantity that is
the unbiased estimator of the distance of the mean matrix from H0 in (2). The proposed testing
methodology is a global procedure that produces a single p-value for testing H0 in (2) and it is not
seriously restricted by the presence of dependence structures other than the independence.
The proposed testing procedure can also be employed to determine the mean relationship between
row and column variables in many predefined sets of row variables rather than across all row variables.
In the motivating examples, the biological interest might lie in finding gene-sets for which the mean
vector of expression levels varies across different tissue samples. This could allow better identification of
biological processes that are tissue-specific, thus facilitating their exploration in greater detail. In this
case, one needs to test hypothesis (1) for each predefined gene-set and then correct the corresponding
p-values for multiple testing. We illustrate how to perform this type of analysis in Section 4.1.
The rest of this article is structured as follows. In Section 2, we introduce the high-dimensional
working framework and we construct the test statistic for testing hypothesis (2). We also discuss
the asymptotic power of the proposed test, we argue that the required assumptions that make the
high-dimensional setting manageable are weak, we make general comments about practical aspects of
the testing procedure and we provide guidelines about how to adjust the proposed methodology to
test hypotheses other than hypothesis (2). In Section 3, we examine the performance of the proposed
testing methodology in finite samples using simulations. In Section 4, we apply the proposed testing
methodology to two microarrays studies where gene expression levels are measured in different tissue
samples (Sottoriva et al., 2013; Zahn et al., 2007). In Section 5, we summarize the main findings of
our research and future research directions.
2 Test Statistics for the Mean Matrix
As the generative process for transposable data, consider a matrix-valued extension of the nonpara-
metric model for vectors considered in Bai and Saranadasa (1996) and Chen and Qin (2010)
Xi =Wi +M (3)
for i = 1, . . . , N , where
1. M = E[Xi] is the r × c mean matrix,
2. Wi is an r× c matrix of random variables such that vec(Wi) = Σ1/2vec(Zi), and where vec(A)
denotes vectorization of the matrix A,
3. Σ = Σ1/2Σ1/2 = cov[vec(Xi)] is an (rc)× (rc) positive-definite covariance matrix,
4. Z1, . . . ,ZN are i.i.d. r × c random matrices and Ziab is the (a, b)-th element of Zi,
5. E[Ziab] = 0, E[Z
2
iab] = 1, E[Z
4
iab] = 3 +B for a finite constant B > −2, E[Z8iab] <∞ and for any
positive integers l1, . . . , lq with
∑q
ν=1 lν ≤ 8
E[Z l1ia1b1Z
l2
ia2b2
. . . Z
lq
iaqbq
] = E[Z l1ia1b1 ]E[Z
l2
ia2b2
] . . .E[Z
lq
iaqbq
]
for (a1, b1) 6= (a2, b2) 6= · · · 6= (aq, bq).
The matrix-variate normal distribution (Dawid, 1981; Gupta and Nagar, 2000), a common and sensible
choice for modeling transposable data, is a special case of model (3). To see this, let Ziab be i.i.d.
random variables from a standard normal distribution N(0, 1) and let Σ = Σ2 ⊗Σ1, where Σ1 is the
covariance matrix of the row variables, Σ2 is the covariance matrix of the column variables and ⊗
denotes the Kronecker product operator applied to matrices. However, we underline that model (3)
is more general. It can handle departures from the matrix-variate normal model by relaxing the
normality and/or the covariance structure assumption. The distribution of the “white-noise” random
variables in Zi remains unspecified. In fact, the white noise random variables do not need to be
3
independent or identically distributed. Also the dependence structure between and among the row
and column variables is not limited to a Kronecker product form.
To construct the test statistic for testing hypothesis (2), we need additional notation. LetP{c1,c2,...,cg} =
diag(Pc1 ,Pc2 , . . . ,Pcg ) be the c × c block diagonal matrix where the positive integers {c1, c2, . . . , cg}
are defined by H0 in (2). For notational ease, suppress the index set in P{c1,c2,...,cg} and write instead
P. Further, note that P is a projection matrix as it is both idempotent and symmetric. The key to
our proposal is to observe that tr(MTMP) = 0 if and only if H0 in (2) holds. To see this, note that
tr(MTMP) = tr(PMTMP) is the sum of squares of the elements of MP, whose (a, b)-th element
equals the difference between µab, the (a, b)-th element of M, and µ¯
(k)
a , the average of the a-th row in
the mean matrix when this is restricted to the column group, say k, to which column b belongs under
H0 in (2). Therefore, it is sensible to consider the unbiased estimator of tr(M
T
MP)
GN =
1
N(N − 1)
∑
i 6=j
tr(XTi XjP),
whose variance is
Var[GN ] =
2
N(N − 1)tr
(
[Σ(P⊗ Ir)]2
)
+
4
N
vec(MP)TΣvec(MP).
Next, we define the asymptotic framework needed to derive the limiting distribution of GN . We
handle the high-dimensional setting without specifying the limiting rate of the pairwise ratios of the
triplet (N, r, c) because in many applications, including our motivating examples, the number of row
(genes) and/or column (multiple samples) variables are not expected to increase proportionally to the
sample size. Instead, we assume that as N → ∞ and rc = r(N)c(N) → ∞, the following conditions
hold:
tr
(
[Σ(P⊗ Ir)]4
)
= o
{
tr2
(
[Σ(P⊗ Ir)]2
)}
(4)
and
vec(MP)TΣvec(MP) = o
{
1
N
tr
(
[Σ(P⊗ Ir)]2
)}
(5)
or
1
N
tr
(
[Σ(P⊗ Ir)]2
)
= o
{
vec(MP)TΣvec(MP)
}
. (6)
The assumption rc→∞ does not require r →∞ and c→∞ simultaneously and it allows the number
of row or column variables to be fixed provided that the other dimension of the transposable data
tends to ∞. Condition (4) specifies the class of covariance matrices for Σ under consideration. In
Section 2.3, we argue that this class is quite large and thus, the proposed testing procedure is not
seriously restricted. At least one of the conditions (5) and (6) is needed to control the asymptotic
variance of GN and to derive the asymptotic distribution of GN , given in Theorem 1 and proven in
the Web Appendix A.
Theorem 1 Under the nonparametric model (3), condition (4) and either condition (5) or condi-
tion (6)
GN − tr(MTMP)√
Var[GN ]
 N(0, 1)
where  denotes convergence in distribution as N → ∞ and rc = r(N)c(N) → ∞. Consequently,
under H0 in (2),
GN√
2tr ([Σ(P⊗ Ir)]2) /[N(N − 1)]
 N(0, 1).
To construct the test statistic, we avoid estimating the unknown and high-dimensional covariance
matrix Σ upon observing that the N i.i.d. rc-variate random vectors Yi = vec(XiP) have covariance
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matrix Ω = (P ⊗ Ir)Σ(P ⊗ Ir) and that tr(Ω2) = tr
(
[Σ(P⊗ Ir)]2
)
. Therefore, it follows from the
work of Chen, Zhang, and Zhong (2010) that
TN =
1
DN2
∑
i 6=j
(YTi Yj)
2 − 2 1
DN3
∑∗
i 6=j 6=k
Y
T
i YjY
T
i Yk +
1
DN4
∑∗
i 6=j 6=k 6=l
Y
T
i YjY
T
kYl
where Dst = (s−t)!/s! and
∑∗ denotes summation over mutually exclusive indices, is a ratio-consistent
estimator of tr(Ω2). Therefore, the proposed test rejects H0 in (2) with an α significance level if and
only if
G∗N =
GN√
2TN/[N(N − 1)]
≥ za,
where za is the upper α-quantile of N(0, 1).
2.1 Remarks
Consider the transformation Xi 7−→ aAXi+C where a 6= 0 ∈ ℜ, A is an r× r orthogonal matrix and
C is an r × c matrix of constants such that CP = 0r×c, and where 0s×t denotes the zero matrix of
size s × t. As desired, the test statistic G∗N is invariant to orthogonal rotations of the row variables,
to scalar multiplication, and to location shifts of the mean matrix under H0 in (2). The last property
implies that the nominal size of the test statistic is not affected by the magnitude of the true mean
matrix M given that this satisfies H0 in (2). To this end, note that column groups of size one do not
contribute to the test statistic, meaning that the value of G∗N does not change if column groups of size
one (ck = 1) are ignored. This is not surprising since no mean comparisons are performed therein.
Hence, these column variables should be removed prior to calculating the test statistic.
Although the testing methodology is presented for testing the mean structure of row variables
across groups of column variables, we emphasize that the same testing procedure can be used to
test the mean structure of column variables across groups of row variables. To do this, apply the
transformation Xi 7−→ XTi prior to calculating G∗N .
A critical point in our proposal is the choice of the projection matrix P. Although Theorem 1 holds
for any projection matrix that satisfies the required assumptions, say P∗, to avoid trivial power under
certain alternatives it is essential to require that MP∗ = 0r×c if and only if the corresponding null
hypothesis is true. For example, an alternative way to test hypothesis (1) is to consider the projection
matrix P∗ = Jc/c (instead of Pc = Ic − Jc/c). The asymptotic power of the resulting test statistic is
trivial if, for example, c is even and the mean vector is µ for the odd columns of M and −µ for the
even columns. Thus attention is required when projection matrices other than the suggested ones are
used.
It is important to note that the testing procedure can be modified and applied to test hypotheses
other than hypothesis (2). For example, consider testing the hypothesis of a known r × c matrix of
constants M0 (H0 : M = M0). To do this, we can center the data by subtracting M0 and then
employ the test statistic G∗N calculated using P = Ic. Another example is testing the hypothesis
H0 : µ1 − µ2 = µ0, where µ1 and µ2 are the unknown r-variate mean vectors of the first and second
column variable respectively, and µ0 is an r-variate vector of known constants. To accomplish this,
one needs to subtract µ0 from the first column of each data matrix and then test hypothesis (2) with
g = 2, c1 = 2 and c2 = . . . = cg = 1 using the transformed data. In a similar way, the proposed
method can be extended to test known differences in the mean vectors of two or more column groups.
To calculate TN , it is more efficient to use the equivalent formula given in Himeno and Yamada
(2014) which reduces the computational cost from O(N4) to O(N2). Combining this result with simple
algebraical properties for the trace operator, we can prove that the proposed testing methodology is
computationally cheap regardless of the dimensionality, i.e., number of row variables, number of column
variables or sample size.
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2.2 Asymptotic power
Under condition (5), the leading order power for the proposed test is
βN = Φ

−za +N tr(MTMP)√
2tr(Ω2)

 ,
where Φ is the cumulative distribution function of N(0, 1). The power of the proposed test is bounded
since
Φ

−za +N tr(MTMP)√
2tr(Σ2)

 ≤ βN ≤ Φ

−za +N tr(MTM)√
2tr(Ω2)

 ,
and thus a sufficient condition for the proposed test to have non-trivial power is
lim
N,(rc)→∞
N
tr(MTMP)√
2tr(Σ2)
> 0.
Under condition (6), the leading order power term becomes
βN = Φ
( √
Ntr(MTMP)
2
√
vec(MP)TΣvec(MP)
)
= Φ
( √
Ntr(MTMP)
2
√
vec(M)TΩvec(M)
)
.
The power of the proposed test remains bounded since
Φ
( √
Ntr(MTMP)
2
√
vec(M)TΣvec(M)
)
≤ βN ≤ Φ
( √
Ntr(MTM)
2
√
vec(M)TΩvec(M)
)
,
which implies that
lim
N,(rc)→∞
√
Ntr(MTMP)
2
√
vec(M)TΣvec(M)
> 0
is a sufficient condition for the proposed test to have non-trivial power.
Although the proposed testing procedure can handle dependence structures other than the in-
dependence, it can still be more powerful than typical univariate tests that require multiple testing
corrections even for independent row and column variables (Σ = Irc). To provide such an instance,
assume a fixed number of column variables and no row-effect in the mean structure, that is Mab =Mb
where Mab is the (a, b)-th element of M. In this scenario, the asymptotic power of the proposed test
under conditions (5) and (6) becomes
Φ

−za +
√
N2r
2(c− g)
g∑
k=1
ck∑
b=ck−1+1
(Mb − M¯ (k))2

 and Φ

r
2
√√√√N g∑
k=1
ck∑
b=ck−1+1
(Mb − M¯ (k))2


respectively, where c0 = 0 and M¯
(k) is the average of the mean of the row variable a in group k.
As desired, under either (5) or (6), the power of the test is an increasing function of the number
of row variables r. On the contrary, the power of some commonly used univariate tests applied
sequentially to each row, such as ANOVA based tests, depends on the magnitude of the differences
{Mb − M¯ (k), b = 1, . . . , c}. Therefore, we expect ANOVA based tests to suffer from low power when
these differences are small regardless of r. Note that we reach to the same conclusion even if we replace
the no row-effect in the mean structure with an unstructured one such that all row-wise differences
{Mab − M¯ (ak), b = 1, . . . , c} are small, and where M¯ (ak) denotes the average of the mean of the row
variable a in group k. In these cases, the proposed test performs better because it extracts information
from both the row and the column variables, which is ignored by univariate tests. We verified this
speculation in simulations where we also investigated the situation in which the null hypothesis under
consideration was violated for varying proportions of the rows in the mean matrix.
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2.3 Class of covariance matrices under consideration
We provide examples of covariance matrices that satisfy condition (4) and technical details can be
found in Web Appendix C. Because of the popularity of the matrix-variate normal distribution in
modelling transposable data, we first study the implications of condition (4) when Σ = Σ2 ⊗Σ1. In
this case, condition (4) becomes
tr
[
(PΣ2)
4
]
tr(Σ41) = o
{
tr2
[
(PΣ2)
2
]
tr2(Σ21)
}
.
For example, this condition is met if tr
[
(PΣ2)
4
]
= o
{
tr2
[
(PΣ2)
2
]}
and/or if tr(Σ41) = o
{
tr2(Σ21)
}
.
This means that Σ1 and/or Σ2 can have bounded eigenvalues or a few eigenvalues that diverge slowly
to infinity (Chen and Qin, 2010), or satisfy a (banded) first order autoregressive correlation pattern
such that the corresponding variances are bounded away from 0 or ∞ (Chen et al., 2010). When
c is fixed, then condition (4) becomes tr(Σ41) = o
{
tr2(Σ21)
}
, and it follows that Σ1 cannot satisfy
a compound symmetry correlation structure. However, if r is fixed, then condition (4) becomes
tr
[
(PΣ2)
4
]
= o
{
tr2
[
(PΣ2)
2
]}
, and therefore the compound symmetry correlation structure is an
acceptable dependence structure for Σ2.
A sufficient assumption for condition (4) in the presence of uncorrelated (not necessarily indepen-
dent) column variables is that tr(Σ4) = o
{
tr2(Σ2)
}
. This assumption covers the case of independent
row and column variables with bounded variances or a few divergent variances among others. When
the row and column variables are correlated, then condition (4) is met for a covariance matrix Σ with
bounded eigenvalues or a few divergent values that diverge slowly, for Σ that implies a (banded) first
order autoregressive correlation pattern or a (banded) compound symmetry correlation matrix.
3 Simulation Studies
We investigated the nominal size and the power of the proposed testing procedure using simulations.
The simulated random matrices X1, . . . ,XN satisfied model (3). To study the nonparametric nature
of the proposed methodology, three distributional scenarios were considered for the elements of Zi:
1. A normality scenario, in which Ziab
i.i.d∼ N(0, 1).
2. A centralized gamma distributional scenario, in which Ziab = (Z
∗
iab−8)/4 and Z∗iab
i.i.d∼ Gamma(4, 0.5).
3. A mixture of Scenarios 1 and 2, in which the random variables in the upper half of Zi are
distributed as in Scenario 1, while the remaining random variables are distributed as in Scenario
2.
Conditional on N , M, Σ and the distributional scenario, we draw 1000 replicates while keeping the
significance level fixed at 5%. For each competing testing procedure, we calculated the empirical size
as the proportion of rejections whenM = 0r×c and the empirical power as the proportion of rejections
when M 6= 0r×c as defined in Sections 3.1 and 3.4. To distinguish the test statistics of the proposed
methodology used in the simulations, we denoted by H{c1,c2,...,cg} the test statistic G
∗
N of the proposed
methodology based on P{c1,c2,...,cg}. Further, we let [k] denote the integer part of k ∈ ℜ. Additional
simulation studies for the proposed testing methodology can be found on the Web Appendix B.
3.1 Comparison with ANOVA and Kruskal-Wallis
We first compared the proposed testing methodology, evaluated using H{c}, to the ANOVA test of no
group effect and the Kruskal-Wallis test for testing the hypothesis of no column effect in the mean
matrix, i.e., testing hypothesis (1). The ANOVA and Kruskal-Wallis tests were applied sequentially to
each of the r row variables and the resulting p-values were adjusted using the false discovery rate (FDR)
correction and the Bonferroni (BON) correction. Web Table 2 suggests that the ANOVA and Kruskal-
Wallis tests are extremely conservative in the presence of row-wise and column-wise dependencies and
therefore, a fair and meaningful comparison is ensured by restricting the dependence structure to
independent row and column variables (Σ = Irc). In addition to calculating the empirical size, we
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Table 1: Empirical size and power of H{10}, ANOVA and Kruskal-Wallis test at 5% significance.
ANOVA Kruskal-Wallis
H{10} FDR BON FDR BON
r N Power Size Power Size Power Size Power Size Power Size
100 10 0.138 0.063 0.051 0.047 0.051 0.046 0.013 0.014 0.013 0.014
30 0.412 0.057 0.091 0.045 0.088 0.045 0.062 0.040 0.060 0.039
50 0.756 0.053 0.136 0.045 0.125 0.044 0.115 0.043 0.112 0.043
100 0.997 0.044 0.319 0.047 0.294 0.045 0.317 0.048 0.285 0.047
500 10 0.186 0.063 0.075 0.066 0.075 0.066 0.011 0.008 0.011 0.008
30 0.703 0.039 0.096 0.060 0.094 0.059 0.051 0.033 0.047 0.033
50 0.974 0.040 0.102 0.042 0.093 0.040 0.082 0.026 0.077 0.026
100 1.000 0.051 0.261 0.054 0.244 0.053 0.253 0.048 0.233 0.047
measured the empirical power of the competing tests assuming that M = [0r×7, tJr×3] where Jk×l
denotes the k× l matrix of ones. This configuration is motivated by the power analysis in Section 2.2.
The constant t was selected such that tr(MTM)/
√
r(c− 1) = 0.1, i.e., by fixing the quantity that
determines the upper bound of the asymptotic power of the proposed tests under condition (5) equal to
0.1. In this way, the asymptotic power of H{c} is not trivial and the simulation results are comparable
across varying values of r and c. Table 1 displays the results under Scenario 3 - similar patterns
were observed under the other two scenarios. Unlike the Kruskal-Wallis test which seemed to be
conservative unless N = 100, the empirical sizes for H{c} and for the ANOVA test appeared to be
a good approximation of the nominal size even for N = 10. Despite the conservativeness of the
proposed test for N = 10, it was always more powerful than the ANOVA and the Kruskal-Wallis
test. Conditional on N and the distributional scenario, the empirical power of the proposed test
increased as r increased while that of the competing testing procedures did not change much even
when N = 100. This is due to the effectiveness of the proposed test in high-dimensional settings when
the magnitude of the row-wise (column-wise) difference in the mean matrix is small but constant for
every row (column) of the mean structure.
Next, we compared the empirical power of the competing testing procedures under a sparsity
scenario for the mean structure. In particular, we definedM = [0r×9,µ] and similarly to Chen and Qin
(2010), we let the r-variate vector µ contain a varying proportion (0%, 25%, 50%, 75%, 95% and 99%)
of zero elements. At each proportion level, we employed a linearly increasing allocation where two
nonzero-elements of µ satisfy µl1 < µl2 if and only if l1 < l2. We set r = 100, 500, 1000 and we let
Σ = I10r. To make the results comparable across the sampling schemes, the non-zero elements of µ
were defined in such a way that
tr(MTM)√
r(c− 1) = 0.15.
Table 2 displays the simulation results only for r = 1000 under Scenario 3 since similar trends were
noted for the remaining sampling schemes. As desired, the empirical power of the proposed method-
ology appeared to be unaffected by the proportion of zero elements in µ for fixed N and the empirical
power approached 1.00 as soon as N = 50. However, the empirical power of the ANOVA and Kruskal-
Wallis tests seemed to decrease as the proportion of zero elements decreased. In fact, the largest
differences between the empirical power of the proposed test and of the univariate tests were observed
when there were no zeros in µ. This agrees with our claims in Section 2.2 regarding the power of the
competing procedures. For 1% of non-zero elements in µ, the empirical powers of the three testing
procedures were comparable unless N = 30 in which case the ANOVA and Kruskal-Wallis tests were
substantially more powerful than the proposed test. For all other proportions of zero elements in µ,
the proposed test was extremely more powerful than the univariate tests with the sole exception of the
sampling scheme with N = 100 and 75% of zero elements in µ. Overall, the proposed test appeared to
be more powerful than univariate tests under the sparsity scenario for the mean matrix and under the
rather unrealistic assumption of independent row and column variables for the dependence structure.
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Table 2: Empirical power of H{10}, ANOVA and Kruskal-Wallis for the sparsity scenario with r = 1000
under Scenario 3 at 5% significance
H{10} ANOVA Kruskal-Wallis
N #{µl = 0} FDR BON FDR BON
10 99% 0.164 0.189 0.184 0.014 0.014
95% 0.170 0.068 0.067 0.003 0.003
75% 0.162 0.062 0.061 0.003 0.003
50% 0.164 0.061 0.060 0.003 0.003
25% 0.161 0.061 0.060 0.004 0.004
0 % 0.168 0.058 0.057 0.003 0.003
30 99% 0.618 0.997 0.997 0.976 0.971
95% 0.624 0.254 0.242 0.132 0.125
75% 0.618 0.096 0.091 0.052 0.050
50% 0.626 0.082 0.080 0.044 0.043
25% 0.628 0.081 0.078 0.047 0.045
0 % 0.625 0.084 0.081 0.051 0.049
50 99% 0.949 1.000 1.000 1.000 1.000
95% 0.948 0.721 0.678 0.566 0.538
75% 0.949 0.144 0.135 0.103 0.100
50% 0.943 0.117 0.108 0.080 0.078
25% 0.944 0.105 0.102 0.078 0.077
0 % 0.944 0.094 0.092 0.076 0.073
100 99% 1.000 1.000 1.000 1.000 1.000
95% 1.000 1.000 1.000 1.000 0.999
75% 1.000 0.398 0.356 0.314 0.290
50% 1.000 0.245 0.229 0.192 0.176
25% 1.000 0.197 0.180 0.157 0.148
0 % 1.000 0.163 0.152 0.155 0.142
Similar trends were observed for an equal allocation scenario in µ (see Web Table 3).
3.2 Comparison with the Chen-Qin test
Suppose we want to test hypothesis (1) when the column variables are independent. In this case, we
can create c groups, one group for each column variable that contains N independent r-variate random
vectors. An alternative practical approach to test hypothesis (1) is to apply the two-sample test for
high-dimensional mean vectors proposed by Chen and Qin (2010) to all possible pairs of groups, and
then adjust the resulting p-values for multiple testing. To satisfy the required assumptions of the
Chen-Qin test, Σ was set equal to a block diagonal matrix with c blocks. Each block of Σ satisfied
a first-order autoregressive form ({ρ|a−b|}1≤a,b≤r) where ρ = 0.5 in the first c/2 blocks and ρ = 0.4
elsewhere. Table 3 shows the empirical sizes of the two competing testing procedures across the three
distributional scenarios with c = 10. The proposed test seemed to preserve the nominal size but the
Chen-Qin test appeared to have a highly inflated empirical size even when r = 1000, which prohibited
us from conducting power comparisons.
3.3 Nominal size
Using H{c}, H{[0.7c],[0.3c]} and H{[0.5c],[0.2c],[0.3c]}, we examined in greater detail the size of the proposed
methodology with non-independence dependence patterns. In particular, we assumed that Σ = Σ2 ⊗
Σ1 where Σ1 = {0.85|a−b|}1≤a,b≤r and Σ2 = 0.5(Ic + Jc) and we employed an exchangeable form
for Σ but since the results were similar, we present only the simulations with the Kronecker product
dependence structure. To reflect practical situations where the dimension of the mean vector is at
least equal to the sample size (N) and the number of row variables (r) is greater or equal to the
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Table 3: Empirical size of H{10} and the Chen-Qin test (with a Bonferroni correction) at 5% signifi-
cance.
Scenario 1 Scenario 2 Scenario 3
r N H{10} Chen-Qin H{10} Chen-Qin H{10} Chen-Qin
100 10 0.048 0.179 0.066 0.179 0.065 0.173
20 0.050 0.144 0.058 0.150 0.059 0.144
30 0.059 0.147 0.069 0.157 0.056 0.158
50 0.057 0.142 0.046 0.126 0.063 0.169
500 10 0.045 0.114 0.059 0.104 0.057 0.097
20 0.051 0.115 0.046 0.090 0.054 0.091
30 0.054 0.084 0.046 0.081 0.040 0.078
50 0.054 0.091 0.050 0.090 0.050 0.077
1000 10 0.060 0.093 0.051 0.081 0.057 0.087
20 0.053 0.080 0.059 0.068 0.046 0.090
30 0.046 0.068 0.059 0.089 0.061 0.073
50 0.042 0.067 0.051 0.075 0.052 0.067
number of column variables (c), we set N = 10, 30, 50, 100, r = 100, 500, 1000 and c = 10, 100. Also,
we covered the case where the number of row variables is much smaller than the number of column
variables by using r = 10 and c = 100, 500. Table 4 contains the empirical sizes under Scenario 3.
Again, similar results were observed for the other two distributional scenarios, a fact that validates
empirically the non-parametric nature of the methodology. The discrepancy between the empirical
and nominal size was small for all three test statistics which confirms the robustness of the proposed
testing procedure to the number of groups and to the group sizes.
3.4 Power considerations
Using H{c}, H{[0.6c],[0.4c]} and H{[0.4c],[0.2c],[0.4c]}, we also evaluated the empirical power of the proposed
methodology under a multiplicative mean vectors scenario. In particular, we letM = [Jr×[0.9c], tJr×[0.1c]],
where t = 1.15, Σ1 = {0.85|a−b|}1≤a,b≤r and Σ2 = 0.5(Ic + Jc) for r = 100, 500, 1000 and c = 10, 100.
Table 5 displays the simulation results based on H{c} across the three distributional scenarios. The
tests based on H{[0.6c],[0.4c]} and H{[0.4c],[0.2c],[0.4c]} were more powerful and hence we do not show these
results. Conditional on N , r and c, the empirical power was similar across the three distributional
scenario and, as desired, it approached 1.00 as the sample size, the number of row or column variables
increased.
4 Two Examples
We applied the proposed testing methodology to two datasets.
4.1 The glioblastoma dataset
The glioblastoma (GB) dataset describes an experimental study designed to explore the heterogeneity
of GB (Sottoriva et al., 2013) by comparing the gene expression patterns in 3 different brain compart-
ments; the tumor margin (MA), normal brain tissue that surrounds the tumor mass, the subventricular
zone (SVZ), a targeted area located at the center of the brain, and the tumor mass. For each of the
patients (N = 8) included in the study, 7 mRNA samples were extracted; 1 from the MA, 1 from the
SVZ and 5 from different fragments in the tumor mass such that earlier fragments were closer to MA
and later fragments closer to SVZ. Gene expression levels were then measured from the 7 × 8 = 56
mRNA samples using microarrays. The data for each subject were organized in a matrix with row
variables (r = 16810) the genes and column variables (c = 7) the MA, the SVZ and the 5 tumor
fragments ordered in the spatial order described above.
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Table 4: Empirical size of the proposed methodology under Scenario 3 and a Kronecker product
dependence structure at 5% significance.
N r H{c} H{[0.7c],[0.3c]} H{[0.5c],[0.2c],[0.3c]}
c 10 100 10 100 10 100
10 100 0.064 0.056 0.059 0.056 0.057 0.058
500 0.068 0.067 0.068 0.067 0.060 0.067
1000 0.058 0.065 0.060 0.057 0.060 0.060
30 100 0.063 0.053 0.061 0.050 0.060 0.049
500 0.049 0.054 0.053 0.048 0.049 0.049
1000 0.049 0.057 0.048 0.063 0.056 0.056
50 100 0.058 0.046 0.059 0.048 0.064 0.048
500 0.060 0.058 0.066 0.062 0.054 0.059
1000 0.047 0.044 0.047 0.042 0.039 0.045
100 100 0.047 0.055 0.050 0.053 0.057 0.058
500 0.047 0.048 0.049 0.040 0.048 0.044
1000 0.051 0.068 0.055 0.068 0.051 0.067
c 100 500 100 500 100 500
10 10 0.055 0.065 0.052 0.067 0.052 0.068
30 10 0.061 0.059 0.057 0.058 0.057 0.055
50 10 0.054 0.053 0.057 0.053 0.056 0.054
100 10 0.062 0.045 0.065 0.045 0.058 0.045
Table 5: Empirical power of H{c} for the multiplicity scenario at 5% significance.
c 10 100 10 100 10 100
N r Scenario 1 Scenario 2 Scenario 3
10 100 0.097 0.317 0.128 0.282 0.103 0.303
500 0.210 0.778 0.207 0.813 0.206 0.781
1000 0.331 0.967 0.305 0.971 0.315 0.965
30 100 0.291 0.975 0.313 0.964 0.294 0.966
500 0.809 1.000 0.782 1.000 0.790 1.000
1000 0.979 1.000 0.965 1.000 0.971 1.000
50 100 0.590 1.000 0.551 1.000 0.576 1.000
500 0.997 1.000 0.992 1.000 0.998 1.000
1000 1.000 1.000 1.000 1.000 1.000 1.000
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An important biological hypothesis was the conservation of the mean vectors of gene expression
levels across the tumor mass. Statistically speaking, this corresponds to testing the hypothesis
H0 :M = [µ1,µ2,µ31
T
5 ] vs. H1 : not H0, (7)
where µ1 and µ2 denote the mean vector of gene expression levels in the MA and the SVZ respectively,
and µ3 denotes the common mean vector of gene expression levels in each of the 5 tumor fragments.
The corresponding test statistic was equal to −0.282 (p-value= 0.611) suggesting that we did not have
enough evidence to reject H0 in (7). This motivated us to assess the likelihood of a simpler mean
structure than the one tested in (7) (see Web Table 1). These results suggest that the overall gene ex-
pression patterns differed across the 3 brain compartments under study and thus,M = [µ1,µ2,µ31
T
5 ]
described adequately the compartment-wise mean relationship in the GB dataset.
We compared further the mean gene expression patterns in the MA and the tumor mass by utilizing
Gene Ontology (GO) terms. The GO terms classify genes into groups such that the genes within a
group are involved in the same biological process. From the 1316 gene groups in the GB dataset,
we selected 231 groups that had more than 7 genes in order to be closer to the high-dimensional
assumptions. For the k-th group of genes (k = 1, . . . , 231) with mean matrix Mk, we tested the
hypothesis
H0k :Mk = [µ1k,µ2k,µ1k1
T
5 ] vs. H1k : not H0k,
where µ1k denotes the common mean gene expression levels vector in the MA and in the 5 tumor
fragments, and µ2k denotes the mean gene expression levels vector in the SVZ. After applying an
FDR correction, we rejected the null hypothesis in 224 groups. The high-proportion of rejections
(96.97%) supports the adopted form for the overall mean matrix M. Many of these 224 gene-groups
correspond to biological processes that are known to be directly linked to cancer, including cellular
response to hypoxia and the extracellular matrix organization (Gilkes et al., 2014), negative regulation
of retinoic acid receptor signaling pathway (Tang and Gudas, 2011; Connolly et al., 2013) and positive
regulation of ERK1 and ERK2 cascade (Santamaria and Nebreda, 2010) among others. Thus, rejecting
the corresponding H0k can be biologically justified.
4.2 The mouse aging dataset
The atlas of gene expression in the mouse aging data (Zahn et al., 2007) contains mouse mRNA gene
expression levels measured in different tissues. For each mouse (N = 40), mRNA expression levels were
extracted for r = 8932 genes from up to 16 tissues. Here, we considered c = 9 tissues (adrenal glands,
cerebrum, hippocampus, kidney, lung, muscle, spinal cord, spleen and thymus) for which mRNA gene
expression levels were available for all the mice.
Unsurprisingly, the hypothesis of no tissue effect upon the mean expression level was rejected since
G∗N = 481.28 (p-value< 0.001). A subset of genes called ‘housekeeping’ genes are typically assumed
to be expressed at a relatively constant level across many or all known experimental conditions. As
a result, these genes are often used to calibrate gene expression levels across experiments. However,
it has been suggested that commonly used housekeeping genes can show considerable variability in
expression across tissues (de Jonge et al., 2007; Kouadjo et al., 2007). To explore this, we created a
list of 22 housekeeping genes compromised of 8 genes that are commonly classified as housekeeping
genes (de Jonge et al., 2007) and 14 genes that were classified as housekeeping genes by de Jonge et al.
(2007). The hypothesis of conservation of the mean expression levels of this gene-set across the 9 tissues
was rejected (G∗N = 382.93 and p-value< 0.001). We believe that further research is required in order
to identify housekeeping genes for these 9 tissues and the proposed testing methodology is a useful
statistical tool to this direction.
5 Discussion
We proposed a novel non-parametric procedure to test the mean matrix in high-dimensional transpos-
able data. In particular, our methodology can determine whether in each of the given groups of column
variables the mean of every row variable remains constant. Of course, the role of the row and column
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variables is interchangeable in transposable data and hence the proposed tests can be applied to check
the effect of the row variables upon the mean vector of the column variables. The simulation studies
verified the robustness of the proposed testing procedure to the number of row or column groups, to
the size of each group, to the number of column and row variables relative to the sample size, and to
the underlying dependence structure between and among the row and column variables. In simula-
tions, the proposed tests were more powerful than univariate testing procedures that require row-wise
and/or column-wise independence in almost all settings. In a sense, we developed a theoretically sound
non-parametric testing procedure that extends the application of univariate ANOVA flavored tests to
high-dimensional transposable data while making mild dependence structure assumptions. The prac-
tical advantage of the proposed test is its computationally simplicity since the cumbersome task of
estimating high-dimensional matrix parameters, such as the mean matrix and the covariance matrix,
is avoided. The proposed testing methodology is implemented in the function meanmat.ts() of the R
package HDTD (aavailable at http://www.bioconductor.org/packages/3.0/bioc/html/HDTD.html).
In practice, we expect that the experimental design will dictate the null hypothesis of interest about
the mean-relationship between the row and column variables, as was the case with the glioblastoma
dataset. In applications where it is not clear which column (or row) groups should be formed under the
null hypothesis, the following strategy that can be helpful in determining the column-wise (row-wise)
structure. First, test whether there is no column (row) effect upon the mean of the row (column)
variables. If we fail to reject this hypothesis, assume that the mean of the row (column) variables
is independent of the column (row) variables. Otherwise, perform the test that two column (row)
variables have the same mean vector for all pairs of column (row) variables, and then adjust for
multiple testing using an FDR or a Bonferroni correction. If all the adjusted p-values are very small,
then assume an unstructured mean matrix M or transpose the data and repeat the above procedure
for the column (row) variables. Otherwise, record the column (row) pairs for which the adjusted
p-values< 0.05, form g column (row) groups and test hypothesis (2) as this is determined by the g
groups.
In future work, we aim to develop test statistics for hypotheses that cannot be directly handled by
the proposed testing methodology, e.g. the hypothesis of a mean-restricted matrix (Allen and Tibshirani,
2010), that isM = µ1Tc +1rν
T where µ is an r-variate vector of constants and ν is a c-variate vector
of constants, and hypotheses of testing simultaneously the presence of predefined row and column
groups.
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Web Appendix A: Proof of Theorem 1
Without loss of generality, let P be an idempotent and symmetric matrix that satisfies condition (4)
and either condition (5) or condition (6). Define Yi = vec(XiP) for all i, where E[Yi] = vec(MP)
and cov[Yi] = Ω = (P⊗ Ir)Σ(P⊗ Ir). Rewrite relations (4), (5) and (6) as
tr(Ω4) = o
{
tr2(Ω2)
}
,
vec(M)TΩvec(M) = o
{
tr(Ω2)/N
}
and
tr(Ω2)/N = o
{
vec(M)TΩvec(M)
}
respectively, and note that
GN =
1
N(N − 1)
∑
i 6=j
tr(XTi XjP) =
1
N(N − 1)
∑
i 6=j
Y
T
i Yj.
With this parameterization, the asymptotic distribution of (GN − E[GN ])/
√
Var[GN ] can be derived
in a similar fashion as in the proof of Theorem 1 in Chen and Qin (2010).
Web Appendix B: Additional Simulation Results
Web Table 2 displays the empirical size of the ANOVA test and the Kruskal-Wallis test in the presence
of row-wise and column-wise dependence. In particular, it was assumed that Σ = Σ2 ⊗ Σ1 where
Σ1 = {0.85|a−b|}1≤a,b≤r and Σ2 = 0.5(Ic + Jc) so that the results are comparable to those in Table 4.
Unlike to the proposed testing methodology, the nominal size was not preserved for the univariate tests.
In fact, the ANOVA test and the Kruskal-Wallis test failed to reject the null hypothesis throughout
this sampling scheme. This suggests that practical approaches might not be suitable to use with
high-dimensional transposable data.
Moreover, we considered the empirical power of the competing testing procedures (proposed tests,
ANOVA and Kruskal-Wallis approaches) under a sparsity scenario for the mean structure, M =
[0r×9,µ], and with an equal allocation for the varying proportion (0%, 25%, 50%, 75%, 95% and 99%)
of zero elements in µ. We set r = 100, 500, 1000 and we let Σ = I10r. To make the results comparable
across the sampling schemes, the non-zero elements of µ were defined in such a way that
tr(MTM)√
r(c− 1) = 0.15.
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Web Table 4 displays the simulation results only for r = 1000 under Scenario 3 because we observed
similar trends for the other 8 sampling schemes. The same conclusions as those with an increasing
allocation (see Table 2) can be drawn. Therefore, the empirical power of the proposed test did not
seem to be affected by the type of allocation of the non-zero elements in µ.
We considered a sparsity scenario for the mean matrix configuration under non-independence of
the row and column variables. We evaluated the empirical power of the proposed testing methodology
via H{c}, H{[0.6c],[0.4c]} and H{[0.4c],[0.2c],[0.4c]}. We defined M = [0
T
r×[0.7c],µ1
T
[0.3c]] and similarly to
Chen and Qin (2010), we let µ contain a varying proportion (0%, 25%, 50%, 75%, 95% and 99%)
of zero elements. At each proportion level, we employed two types of allocations for the non-zero
elements: (i) equal allocation and (ii) linearly increasing allocation where two nonzero-elements of µ
satisfy µl1 < µl2 if and only if l1 < l2. We set r = 100, c = 10 and we used a Kronecker product form
for Σ with Σ1 = {0.8|a−b|}1≤a,b≤r and Σ2 = 0.5(Ic + Jc). To make the results comparable across the
different proportion levels, the non-zero elements of µ were defined in such a way that
tr(MTM)√
tr(Σ21)tr(Σ
2
2)
= 0.1.
Table 4 displays the simulation results for H{6,4}. Similar trends occurred for H{4,2,4} but not for
H{10}, which was extremely powerful in these settings. This indicates that as we move away from H0,
the power of the proposed methodology increases. Conditional on the sample size, the empirical power
was similar across the three distributional scenario and it did not depend on the type of allocation or
the proportion level. The proposed testing procedure was powerful to the sparsity scenarios considered
and their empirical power approached 1.00 as N increased.
Finally, we increased r = 10, 000 and we let c = 1000, N = 10, 30, 50 and Σ = I10r under
Scenario 3. For the mean structure, we assumed the same configuration as in Table 2. In addition
we calculated the empirical size. The results for the proposed method are displayed in Web Table 5.
Clearly, increasing r does not affects the conclusions drawn in Table 2 as long as we keep
tr(MTM)√
r(c− 1)
fixed.
Web Appendix C: Class of Covariance Matrices under Consideration
Let λk(∆) denote the k-th ordered eigenvalue of a p× p symmetric matrix ∆ such that
λrc(∆) ≤ λrc−1(∆) ≤ . . . ≤ λ1(∆),
and recall that
P = P{c1,c2,...,cg} = Ic − diag(Jc1/c1,Jc2/c2, . . . ,Jcg/cg) = Ic −Hc
where the integers {c1, . . . , cg} satisfy the constraint c1 + c2 + . . .+ cg = c.
Suppose that Σ = Σ2 ⊗Σ1 in which case
tr(Ω4)
tr2(Ω2)
=
tr
[
(PΣ2)
4
]
tr2 [(PΣ2)2]
tr(Σ41)
tr2(Σ21)
.
If tr(Σ41) = o
{
tr2(Σ21)
}
, then condition (4) is satisfied. Now we prove that condition (4) is also met
when tr(Σ42) = o
{
tr2(Σ22)
}
. First, note that
λ41(Σ2)
tr2(Σ22)
≤
∑rc
k=1 λ
4
k(Σ2)
tr2(Σ22)
=
tr(Σ42)
tr2(Σ22)
,
2
and thus the condition tr(Σ42) = o
{
tr2(Σ22)
}
implies that λ1(Σ2) = o
{√
tr(Σ22)
}
. Now write
tr
[
(PΣ2)
2
]
= tr(Σ22) + tr(HcΣ2HcΣ2)− 2tr(HcΣ22)
and note that
0 ≤ tr(HcΣ2HcΣ2) ≤ tr(HcΣ22) ≤
g∑
k=1
λk(Hc)λk(Σ
2
2) ≤
g∑
k=1
λ2k(Σ2) ≤ gλ21(Σ2).
It follows that
tr
[
(PΣ2)
2
]
tr
(
Σ
2
2
) → 1
and hence
tr
[
(PΣ2)
4
]
tr2 [(PΣ2)2]
→ 0.
The above prove that Σ1 and/or Σ2 belong to the class of covariance matrices ∆ for which tr(∆
4) =
o
{
tr2(∆2)
}
. This class includes covariance matrices that have bounded eigenvalues or have a few
eigenvalues that diverge slowly to infinity (Chen and Qin, 2010) or when Σ1 and Σ2 a (banded)
first order autoregressive correlation pattern such that the variances are bounded away from 0 or ∞
(Chen et al., 2010). Under the Kronecker product structure, when c→∞ andΣ2 satisfies a compound
symmetry correlation matrix, i.e., Σ2 = ρIc + (1− ρ)Jc for −1/(c− 1) < ρ ≤ 1, it can be shown that
tr(Ω4)
tr2(Ω2)
≤ tr
[
(PΣ2)
4
]
tr2 [(PΣ2)2]
=
(1− ρ)4(c− g)
[(1− ρ)2(c− g)]2 → 0.
Next, suppose that the column variables are uncorrelated, in which case Σ is a block diagonal
matrix and tr(Σ4) = o
{
tr2(Σ2)
}
. We prove that condition (4) holds when Hc = Jc/c. The proof
is similar when Hc = diag(Jc1/c1,Jc2/c2, . . . ,Jcg/cg). Let H = Hc ⊗ Ir. Some algebra shows that
tr(HΣ2) = tr(Σ2)/c and tr(HΣHΣ) > tr(Σ2)/c2, and consequently
tr(Ω2) = tr(Σ2) + tr(HΣHΣ)− 2tr(HΣ2) ≥ (1− 1/c)2tr(Σ2) ≥ tr(Σ2)/2.
Therefore
tr(Ω4)
tr2(Ω2)
≤ 4 tr(Σ
4)
tr2(Σ2)
→ 0.
Finally, assume that neither the rows nor the columns are independent. By the Pioncare seperation
theorem, it follows that
λrg+k(Σ) ≤ λk(Ω) ≤ λk(Σ)
for k = 1, . . . , r(c− g) and that λr(c−g)+1(Ω) = . . . = λrc(Ω) = 0. Assume first that Σ has eigenvalues
bounded away from zero and infinity, i.e., there exist constants L and U such that
0 < L ≤ λrc(Σ) ≤ . . . ≤ λ1(Σ) ≤ U <∞
then
tr(Ω4)
tr2(Ω2)
≤ 1
r(r − g)
U4
L4
→ 0
as rc → ∞. It can be shown that condition (4) holds even if Σ has unbounded eigenvalues with
λ1(Σ) → ∞ and λrc(Σ) → 0 such that λ1(Σ) = o {r(c− g)λrc(Σ)}. Next assume that Σ =
ρIrc + (1 − ρ)Jrc for −1/(rc − 1) < ρ ≤ 1. For all k = 1, 2, . . ., it can be readily shown that
tr(Ωk) = (1 − ρ)kr(c − g) and thus condition (4) is met. Consider the case where Σ satisfies a first
order autoregressive correlation matrix and Hc = Jc/c. Similar arguments generalize the result for
Hc = diag(Jc1/c1,Jc2/c2, . . . ,Jcg/cg). It can be shown that tr(HcΣ
2) = o
{
tr(HcΣ
2)
}
which implies
condition (4).
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WebTable 1: Hypothesis testing results regarding the global mean structure in the GB study.
p−value
Mean matrix under H0 Test statistic Unadjusted FDR correction
M = [µ1,µ2,µ31
T
5 ] -0.2818 0.6110 0.6110
M = [µ1,µ1,µ31
T
5 ] 15.2426 <0.0001 <0.0001
M = [µ1,µ2,µ21
T
5 ] 3.0211 0.0013 0.0016
M = [µ1,µ2,µ11
T
5 ] 22.2515 <0.0001 <0.0001
M = [µ1,µ1,µ11
T
5 ] 22.5101 <0.0001 <0.0001
WebTable 2: Empirical sizes of ANOVA and Kruskal-Wallis test under Scenario 3 and under a Kro-
necker product dependence structure at 5% significance.
ANOVA Kruskal-Wallis
N r FDR BON FDR BON
10 100 0.000 0.000 0.000 0.000
500 0.000 0.000 0.000 0.000
30 100 0.000 0.000 0.000 0.000
500 0.000 0.000 0.000 0.000
50 100 0.000 0.000 0.000 0.000
500 0.000 0.000 0.000 0.000
100 100 0.000 0.000 0.000 0.000
500 0.000 0.000 0.000 0.000
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WebTable 3: Empirical power of H{10}, ANOVA and Kruskal-Wallis for the sparsity scenario with
r = 1000 under Scenario 3 under an equal allocation at 5% significance
H{10} ANOVA Kruskal-Wallis
N #{µl = 0} FDR BON FDR BON
10 99% 0.181 0.214 0.203 0.052 0.051
95% 0.194 0.075 0.074 0.006 0.006
75% 0.193 0.063 0.062 0.003 0.003
50% 0.186 0.064 0.061 0.004 0.004
25% 0.187 0.063 0.058 0.003 0.003
0 % 0.186 0.060 0.058 0.003 0.003
20 99% 0.703 1.000 1.000 1.000 1.000
95% 0.709 0.287 0.273 0.189 0.177
75% 0.696 0.090 0.089 0.050 0.046
50% 0.707 0.076 0.075 0.041 0.040
25% 0.699 0.080 0.077 0.045 0.045
0 % 0.693 0.080 0.076 0.049 0.048
50 99% 0.974 1.000 1.000 1.000 1.000
95% 0.975 0.786 0.739 0.677 0.641
75% 0.976 0.160 0.149 0.122 0.117
50% 0.976 0.123 0.117 0.093 0.089
25% 0.977 0.116 0.115 0.089 0.086
0 % 0.976 0.108 0.105 0.088 0.086
100 99% 1.000 1.000 1.000 1.000 1.000
95% 1.000 1.000 1.000 1.000 1.000
75% 1.000 0.444 0.401 0.372 0.336
50% 1.000 0.235 0.209 0.198 0.185
25% 1.000 0.197 0.185 0.177 0.169
0 % 1.000 0.176 0.164 0.168 0.158
WebTable 4: Empirical power of H{6,4} for the sparsity scenario with r = 100 at 5% significance.
Equal Allocation Increasing Allocation
N #{µl = 0} Scenario 1 Scenario 2 Scenario 3 Scenario 1 Scenario 2 Scenario 3
10 99% 0.194 0.213 0.173 0.194 0.213 0.173
95% 0.175 0.207 0.164 0.172 0.213 0.163
75% 0.166 0.204 0.171 0.168 0.205 0.173
50% 0.174 0.211 0.169 0.172 0.207 0.169
25% 0.173 0.203 0.170 0.169 0.203 0.168
0% 0.167 0.201 0.165 0.164 0.199 0.166
30 99% 0.605 0.609 0.606 0.605 0.609 0.606
95% 0.626 0.582 0.605 0.623 0.589 0.605
75% 0.632 0.634 0.635 0.637 0.637 0.642
50% 0.643 0.646 0.649 0.651 0.648 0.650
25% 0.645 0.647 0.654 0.647 0.645 0.653
0% 0.658 0.644 0.663 0.662 0.643 0.666
50 99% 0.903 0.868 0.882 0.903 0.868 0.882
75% 0.896 0.897 0.899 0.904 0.898 0.896
50% 0.938 0.936 0.934 0.947 0.941 0.936
25% 0.962 0.955 0.949 0.965 0.958 0.954
5% 0.964 0.959 0.954 0.967 0.964 0.958
0% 0.965 0.966 0.961 0.969 0.967 0.963
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WebTable 5: Empirical size and power of H{10} for the sparsity scenario with r = 10000 under Scenario
3 at 5% significance
N #{µl = 0} Scenario 1 Scenario 2 Scenario 3
10 100% 0.055 0.056 0.068
99% 0.181 0.158 0.166
95% 0.176 0.159 0.164
75% 0.178 0.151 0.164
50% 0.180 0.158 0.170
25% 0.181 0.163 0.169
0% 0.182 0.164 0.166
30 100% 0.050 0.054 0.065
99% 0.660 0.591 0.664
95% 0.653 0.599 0.660
75% 0.653 0.586 0.644
50% 0.656 0.592 0.650
25% 0.649 0.588 0.661
0% 0.648 0.596 0.650
50 100% 0.050 0.055 0.039
99% 0.952 0.952 0.953
95% 0.948 0.954 0.943
75% 0.953 0.953 0.944
50% 0.952 0.954 0.947
25% 0.955 0.956 0.947
0% 0.954 0.954 0.952
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